Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Stassen

Showing results (61-70 of 94) with videos related to

Pageof 10
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 21, 2007
A monoamine oxidase B gene variant and short-term antidepressant treatment responseAndré Tadić, Dan Rujescu, Matthias J Müller, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 28, 2025
Genetic predisposition to unwanted side effects under antidepressants and antipsychotics: a molecular-genetic study of 902 patients over 6 weeksHans H Stassen, S Bachmann, R Bridler, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 29, 2006
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depressionAndré Tadić, Matthias J Müller, Dan Rujescu, et al.
Neuropsychiatric Disease and Treatment|August 30, 2008
Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depressionAndré Tadić, Dan Rujescu, Matthias J Müller, et al.
The Pharmacogenomics Journal|November 3, 2004
The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depressionA Szegedi, D Rujescu, A Tadic, et al.
RNA (New York, N.Y.)|September 18, 1998
Characterization of an anti-RNA recombinant autoantibody fragment (scFv) isolated from a phage display library and detailed analysis of its binding site on U1 snRNAS W Teunissen, M H Stassen, G J Pruijn, et al.
American Journal of Medical Genetics|July 14, 2000
Schizophrenia and smoking: evidence for a common neurobiological basis?H H Stassen, R Bridler, S Hägele, et al.
Pharmacopsychiatry|October 1, 2011
Predicting response to psychopharmacological treatment: survey of recent resultsH Stassen, I-G Anghelescu, J Angst, et al.
Psychophysiology|March 31, 1999
EEG differences in monozygotic twins discordant and concordant for schizophreniaH H Stassen, R Coppola, I I Gottesman, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 6, 2017
Inflammatory processes and schizophrenia: two independent lines of evidence from a study of twins discordant and concordant for schizophrenic disordersSilke Braun, René Bridler, Norbert Müller, et al.
Pageof 10

Showing results (61-70 of 94) with videos related to

Sort By:
Pageof 10
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 21, 2007
A monoamine oxidase B gene variant and short-term antidepressant treatment responseAndré Tadić, Dan Rujescu, Matthias J Müller, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 28, 2025
Genetic predisposition to unwanted side effects under antidepressants and antipsychotics: a molecular-genetic study of 902 patients over 6 weeksHans H Stassen, S Bachmann, R Bridler, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|December 29, 2006
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depressionAndré Tadić, Matthias J Müller, Dan Rujescu, et al.
Neuropsychiatric Disease and Treatment|August 30, 2008
Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depressionAndré Tadić, Dan Rujescu, Matthias J Müller, et al.
The Pharmacogenomics Journal|November 3, 2004
The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depressionA Szegedi, D Rujescu, A Tadic, et al.
RNA (New York, N.Y.)|September 18, 1998
Characterization of an anti-RNA recombinant autoantibody fragment (scFv) isolated from a phage display library and detailed analysis of its binding site on U1 snRNAS W Teunissen, M H Stassen, G J Pruijn, et al.
American Journal of Medical Genetics|July 14, 2000
Schizophrenia and smoking: evidence for a common neurobiological basis?H H Stassen, R Bridler, S Hägele, et al.
Pharmacopsychiatry|October 1, 2011
Predicting response to psychopharmacological treatment: survey of recent resultsH Stassen, I-G Anghelescu, J Angst, et al.
Psychophysiology|March 31, 1999
EEG differences in monozygotic twins discordant and concordant for schizophreniaH H Stassen, R Coppola, I I Gottesman, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 6, 2017
Inflammatory processes and schizophrenia: two independent lines of evidence from a study of twins discordant and concordant for schizophrenic disordersSilke Braun, René Bridler, Norbert Müller, et al.
Pageof 10